Long-term follow-up of a cochlear implant that releases medicine
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This study is checking how well a cochlear implant that slowly releases a medicine (dexamethasone) to reduce swelling works over a long time. It is for people who already took part in the main study for this implant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed all parts of the main CI-DEX study (NCT04750642).
- You must have received either a CI632D or a CI632 cochlear implant in that study.
- You must be able to give written permission to be in this new study.
- You cannot have unrealistic ideas about the benefits or risks of the study.
- You cannot have other health problems that would make it hard or unsafe to take part.
- You cannot be in another experimental drug or device study right now or within the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a cochlear implant fitting based on your ear's anatomy helps you hear speech in noisy places and enjoy music more. It is for people who are deaf in one ear and use a MED-EL cochlear implant.
This study tests a new way to adjust the settings on your cochlear implant and hearing aid together. The goal is to improve your hearing by using the natural structure of your ear, which might help you hear better in everyday situations.
This study tests a new type of cochlear implant that is completely placed under the skin, with no external parts. It is for adults with severe hearing loss who still struggle to hear even with hearing aids.
This study follows people who get a cochlear implant – a device that helps restore hearing. It tracks how well you hear over time and checks for any long-term benefits or problems.
This study checks how well long-term care works for people who may use an osseointegrated hearing device (an implanted option that connects to bone). It may help by improving long-term support and outcomes for hearing and day-to-day functioning over about three years.
This trial tests an oral medication, SPI-1005, given to adults receiving a cochlear implant to see if it improves hearing outcomes. It may help people with moderate to profound hearing loss who are scheduled for implant surgery.
Hear when a new Sensorineural Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.